Buphenine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C04AA02,G02CA02
CAS registry number (Chemical Abstracts Service)
0000447-41-6
Chemical Formula
C19-H25-N-O2
Molecular Weight
299
Therapeutic Categories
Peripheral vasodilator
Sympathomimetic agent
Chemical Name
Benzenemetanol, 4-hydroxy-α-[1-[(1-metyl-3-phenylpropyl)amino]etyl]-
Foreign Names
Generic Names
- Bufenina (OS: DCIT)
- Buphenine (OS: BAN)
- Buphénine (OS: DCF)
- CS 6712 (IS)
- Nylidrinum (IS)
- phenyl-butyl-norsuprifene (IS)
- SKF 1700-A (IS)
- Nylidrin Hydrochloride (OS: JAN)
- Nylidrin Hydrochloride (PH: USP XXII)
Brand Names
- Opino (Buphenine and Escin)
Menarini, Greece - PMS-Nylidrin
Pharmascience, Canada
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
